Other

Gross Unrealized Gains

Gilead Sciences Gross Unrealized Gains decreased by 90.9% to $1.00M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2020 to FY 2025), Gross Unrealized Gains shows an upward trend with a 38.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 7, 2026

How to read this metric

An increase indicates favorable market conditions for the fixed-income portfolio, potentially boosting book value.

Detailed definition

The total amount of unrealized gains on debt securities classified as available-for-sale that have not yet been recogniz...

Peer comparison

Standard metric for insurance companies holding large bond portfolios.

Metric ID: other_available_for_sale_debt_securities_accumulated_gro_8d5dbc

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.00M$1.00M$0.00$0.00$0.00$0.00$1.00M$2.00M$0.00$0.00$5.00M$6.00M$10.00M$11.00M$1.00M
QoQ Change+0.0%-100.0%+100.0%-100.0%+20.0%+66.7%+10.0%-90.9%
YoY Change-100.0%-100.0%+400.0%
Range$0.00$11.00M
CAGR+0.0%
Avg YoY Growth+66.7%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Gilead Sciences's gross unrealized gains?
Gilead Sciences (GILD) reported gross unrealized gains of $1.00M in Q1 2026.
What is the long-term trend for Gilead Sciences's gross unrealized gains?
Over 4 years (2020 to 2025), Gilead Sciences's gross unrealized gains has grown at a 38.4% compound annual growth rate (CAGR), from $3.00M to $11.00M.
What does gross unrealized gains mean?
The total paper profit on debt investments that have not been sold yet.